Axa
ARCB icon

Axa’s ArcBest ARCB Stock Holding History

Axa’s Portfolio ARCB Stock Details ARCB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-46,600
Closed -$3.26M – 1107
2022
Q4 		$3.26M Hold
46,600
– – 0.01% 689
2022
Q3 		$3.39M Sell
46,600
-400
-0.9% -$32.2K 0.01% 658
2022
Q2 		$3.31M Buy
47,000
+1,600
+4% +$118K 0.01% 677
2022
Q1 		$3.65M Sell
45,400
-1,700
-4% -$153K 0.01% 732
2021
Q4 		$5.64M Buy
47,100
+39,200
+496% +$3.99M 0.01% 636
2021
Q3 		$646K Buy
7,900
+2,100
+36% +$138K ﹤0.01% 1027
2021
Q2 		$338K Buy
+5,800
New +$415K ﹤0.01% 1156
2018
Q3 		– Sell
-16,200
Closed -$740K – 1329
2018
Q2 		$740K Buy
+16,200
New +$667K ﹤0.01% 1071
2014
Q2 		– Sell
-7,400
Closed -$273K – 1385
2014
Q1 		$273K Hold
7,400
– – ﹤0.01% 1172
2013
Q4 		$249K Buy
+7,400
New +$220K ﹤0.01% 1181

Other funds holding ARCB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Axa's ARCB Position: Q1 2023 in Review

Axa sold out of ArcBest (ARCB) in Q1 2023, closing a stake of 46,600 shares — an estimated $3.26M sold.

Axa first reported a position in ARCB in Q4 2013 and held it in 10 quarters. The position peaked at $5.64M in Q4 2021. 277 funds tracked by Wall St. Rank hold ARCB as of Q1 2023.

  • Axa reported no remaining ArcBest position as of Q1 2023 after selling out during the quarter.
  • Axa sold 46,600 ArcBest shares in Q1 2023, an estimated $3.26M.
  • Axa first reported a position in ArcBest in Q4 2013 and held it in 10 quarters.
  • Axa's ArcBest position peaked at $5.64M in Q4 2021.
  • 277 funds tracked by Wall St. Rank held ArcBest as of Q1 2023.

Based on Axa's 13F filing for Q1 2023, filed 15 May 2023.